Icelandic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

glutamine/bólga

Krækjan er vistuð á klemmuspjaldið
14 niðurstöður

Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION The present invention is a method of using luminal glutamine in the prevention of bacterial translocation and Neonatal Necrotizing Enterocolitis (NEC) in vivo. The same treatment is useful to also protect intestinal cells against injuries caused by other infectious agents,

Composition and method for providing glutamine

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION This invention relates to a nutritional composition for providing glutamine to a human or animal. The invention also relates to a method for providing glutamine to a human or animal and to a method for the treatment of humans and animals requiring supplemental

Peptides which stimulate the expression of the cytokines of inflammation and promote tissue regeneration

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION This invention concerns a new family of peptide molecules having the capacity especially of stimulating the expression of the cytokines of inflammation and promoting regeneration of tissues. The invention, thus, also pertains to pharmaceutical compositions containing at least

Labelled glutamine and lysine analogues

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
The present invention relates to a class of compounds useful in the diagnosis of sites of venous and arterial thrombosis, embolism or infection, pharmaceutical formulations containing them, their use in the diagnosis of disease and methods for their preparation. Prior approaches to thrombus imaging

Therapeutic agent for inflammatory bowel disease and TNF-.alpha. production inhibitor

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
TECHNICAL FIELD The present invention relates to an agent for treating or preventing an inflammatory bowel disease, comprising a particular amino acid(s). The present invention also relates to an agent for inhibiting TNF production, comprising a particular amino acid(s). BACKGROUND ART An

Materials and methods for treatment and diagnosis of disorders associated with oxidative stress

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION Ulcerative colitis (UC) is an inflammatory bowel disease characterized by recurrent bouts of rectal bleeding and bloody diarrhea. The initial inflammatory reaction begins in the rectal mucosa in over 95% of cases and may extend in a contiguous fashion to involve the whole

Materials and methods for treatment and diagnosis of disorders associated with oxidative stress

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION Ulcerative colitis (UC) is an inflammatory bowel disease characterized by recurrent bouts of rectal bleeding and bloody diarrhea. The initial inflammatory reaction begins in the rectal mucosa in over 95% of cases and may extend in a contiguous fashion to involve the whole

Composition and method for reducing diarrhea in a mammal

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION Maintaining the well being of the GI tract of a mammal is a very desirable goal. Particularly annoying are inflammatory conditions of the GI tract. Some of the signs of inflammation of the GI tract include acute or chronic diarrhea, soft stools, blood in stool, vomiting,

Nutritional preparation comprising ribose and medical use thereof

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
The invention is related to nutritional, pharmaceutical or dietetic preparations that comprise ribose or folic acid or functional analogs thereof and the use of these compositions in the prevention or treatment of specific diseases that are related to disorders or insufficiencies of total nucleotide

Nutritional preparation comprising ribose and medical use thereof

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
The invention is related to nutritional, pharmaceutical, or dietetic preparations that comprise ribose or folic acid or functional analogs thereof and the use of these compositions in the prevention or treatment of specific diseases that are related to disorders or insufficient of total nucleotide

Method of treating disorders of the animal or human body by administering amino acids

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
The invention relates to a method of treating disorders of the animal or human body which require increasing blood flow to intestinal organs as well as to a method of treating disorders which can be treated by administering arginine. The present invention relates in particular to the use of

Protective skin care peptides

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION The invention relates to peptides having biological and therapeutic activity. Particularly, the invention relates to tetrapeptides that inhibit inflammatory processes in skin. Such tetrapeptides exert this effect, in part, by reducing the amount of interleukin (IL)-6 and

Antagonists for diseases induced by cells with high-affinity ELR-CXC chemokine receptor proteins

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
CROSS-REFERENCE TO RELATED APPLICATIONS This Non-provisional application claims priority under 35 U.S.C. .sctn.119(a) on Patent Application No. 100138960 filed in Taiwan, Republic of China Oct. 26, 2011, the entire contents of which are hereby incorporated by reference. FIELD OF THE INVENTION This

Covalent bonding of active agents to skin, hair or nails

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION The invention relates to compositions for topical application to human skin, hair, or nails, which compositions contain transglutaminase and a beneficial active ingredient containing, or so modified as to contain, an alkylamine group. BACKGROUND OF THE
Skráðu þig á
facebook síðu okkar

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

  • Virkar á 55 tungumálum
  • Jurtalækningar studdir af vísindum
  • Jurtaviðurkenning eftir ímynd
  • Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
  • Lestu vísindarit sem tengjast leit þinni
  • Leitaðu að lækningajurtum eftir áhrifum þeirra
  • Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum

Google Play badgeApp Store badge